Amgen Says FDA Completes Review Of SNDA Seeking Full Approval For LUMAKRAS

Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris

The U.S. Food and Drug Administration has approved Amgen Inc.'s Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab), developed by British drug major AstraZeneca's Rare Disease unit Alexion Pharmaceuticals, to treat certain rare diseases. Soliris is a medicine used to treat adults and children with paroxysmal nocturnal haemoglobinuria or PNH...

RTTNews | 333 dias atrás

Amgen To Open Manufacturing Site In Central Ohio; To Offer 400 Full-time Jobs

Amgen, Inc. (AMGN) announced Monday the opening of its manufacturing site in Central Ohio, the newest in its global operations network and the most advanced facility to date.

RTTNews | 427 dias atrás

Amgen, Horizon Therapeutics Reach Settlement On FTC Lawsuit; Seeks To Close Acquisition In Q4

Amgen (AMGN) and Horizon Therapeutics plc (HZNP) announced Friday the entry into a consent order agreement with the Federal Trade Commission (FTC) that resolves the pending FTC administrative lawsuit. This clears the path to take the final steps to close Amgen's $27.8 billion acquisition of Horizon.

RTTNews | 605 dias atrás

Amgen Announces Positive Top-line Results From Phase 3 DAHLIA Study Of ABP 959

Amgen, Inc. (AMGN) announced Tuesday positive top-line results from the DAHLIA study, a randomized, double-blind, active-controlled, two-period crossover Phase 3 study evaluating the efficacy and safety of ABP 959, a biosimilar candidate to SOLIRIS (eculizumab), compared with SOLIRIS in adult patients with paroxysmal nocturnal hemoglobinuria (PNH).

RTTNews | 979 dias atrás

U.S. Dollar Falls Against Majors

The U.S. dollar weakened against its major counterparts in the New York session on Monday, as investors focused on upcoming earnings announcements and some crucial U.S. economic data.

RTTNews | 26 minutos atrás

Swiss Market Ends On Firm Note

After a flat start and a subsequent sluggish spell the Switzerland market moved higher on Monday with stocks gradually gaining in strength as the day progressed.

RTTNews | 1 h 53 min atrás

European Stocks Close Broadly Higher Ahead Of Earnings Announcements

European stocks closed higher on Monday, and the U.K. market recorded its longest winning streak in over five years, moving up for the eleventh consecutive session, as investors focused on upcoming earnings announcements and some crucial European and U.S. economic data. Hopes of a de-escalation in U.S.-China trade friction too contribute to the positive mood in the market.

RTTNews | 2 h 5 min atrás

Domino's Pizza Q1 Earnings Beat, Revenues Miss, U.S. Same Store Sales Down; Stock Drops

Domino's Pizza Inc. announced Monday higher earnings in its first quarter, above market estimates, amid revenue growth. Meanwhile, the largest pizza company in the world recorded weak income from operations and U.S. same store sales, and its top line missed the Street view. In pre-market activity on the Nasdaq, Domino's Pizza shares were losing around 2.6 percent.

RTTNews | 6 h 39 min atrás

EURUSD	1.14214	GBPUSD	1.34296	AUDUSD	0.64296
USDJPY	142.084	USDCAD	1.38349	USDCHF	0.82063

Advertisement

Amgen Says FDA Completes Review Of SNDA Seeking Full Approval For LUMAKRAS